New ASI paper: How the UK can be a world leader in medical innovation

The ASI has a new paper out today by Mark Lutter: Instrumental Variables: How the UK can become a world leader in medical innovation.

Lutter argues that the UK must reduce the restrictions on developing new drugs and medical treatments by building a culture and regulatory structure designed around "permissionless innovation"—innovate first, regulate later. People do not just suffer and die from faulty drugs, but also from good drugs being permitted too late. He suggests "reciprocity"—allowing devices and procedures in the UK if they are already permitted in some other highly developed country with similar regulatory standards—as a first step.

Here's the pdf of the whole paper. Here's the PR for the paper.

Here's Marks' twitter, his essays on private governance at Cato Unbound, his page on FEE, his Medium page, and his page at NeWAY Capital, where he's currently employed.